Deloitte
Share:
The 2026 Life Sciences Outlook Survey Results Are In
Deloitte’s 2026 Outlook Survey results reveal a sector defined by “purposeful transformation,” as leaders pivot from AI experimentation to disciplined scaling amid a fragmented global economy. While over 75% of executives remain confident in their own organization’s financial health, only 41% share that optimism for the broader global economy. Strategic roadmaps for 2026 are being shaped by more than just technology. While digital maturity remains essential, life sciences executives are also prioritizing resilience against external pressures like new regulations, pricing volatility, and geopolitical friction. Responsory’s insight: Understanding how to balance aggressive digital transformation with adaptive strategy will separate market leaders from those merely reacting to disruption.
